Bacterial proteomics and its role in antibacterial drug discovery.
about
Breaking the Spell: Combating Multidrug Resistant 'Superbugs'Mass spectrometry-based proteomics and its application to studies of Porphyromonas gingivalis invasion and pathogenicity.Integrative analysis of transcriptomic and proteomic data: challenges, solutions and applications.Postgenomic strategies in antibacterial drug discovery.Challenges of antibacterial discoveryTwo-dimensional gels for toxicological drug discovery applications.Proteomics in leptospirosis research: towards molecular diagnostics and vaccine development.Proteomic signatures uncover thiol-specific electrophile resistance mechanisms in Bacillus subtilis.Proteomic signatures in antibiotic research.Using 'omic' technology to target Helicobacter pylori.Systems biology of cyanobacterial secondary metabolite production and its role in drug discovery.Preclinical Assessment of a 68Ga-DOTA-Functionalized Depsipeptide as a Radiodiagnostic Infection Imaging Agent.2-DE analysis indicates that Acinetobacter baumannii displays a robust and versatile metabolism.Proteomic signature of fatty acid biosynthesis inhibition available for in vivo mechanism-of-action studies.Evaluating the suitability of essential genes as targets for antibiotic screening assays using proteomicsDifferential proteomic analysis of the response of Stenotrophomonas maltophilia to imipenem.Stress response of Escherichia coli to essential oil components - insights on low-molecular-weight proteins from MALDI-TOF2-D Gel-Based Proteomic Approaches to Antibiotic Drug Discovery
P2860
Q26765868-C8D19A60-D44B-4403-A500-97D1ABAE471DQ30439892-14A170FC-0388-438A-98FC-3057A39FC592Q31116249-1EB4FF8E-35AD-453C-8463-154585F6FAFBQ33745572-F36AD270-A15C-4CED-B01B-A2DC27B82B1BQ33793074-25099470-881C-4E53-9F0C-6F8BD77B449BQ36545048-1CC38C63-2320-42FB-88D8-390BB0ECCC97Q37035272-4AFACF24-F5ED-4D65-BE0A-116361772678Q37087384-80558910-7C1E-486E-B0B8-1BE9A9A9FDDCQ37897212-73961C4E-765F-43A2-BC43-25CA24AC506DQ38088779-CABB488E-E760-45D3-AFEA-05187F8B5717Q38088802-EF8E557F-F14D-4BA5-8474-77F02FC3F4C4Q40081284-4E29A907-5EE5-45AE-90BF-2DE75A3BBE9BQ42583566-B02BC4D4-8433-4632-BA9B-AF8BD1551C94Q42738828-E2A670B3-9712-4612-B251-5E67DD70B664Q42772236-92A0C4E3-7C3B-4FBC-BD96-BADAACFEC17FQ49161535-25CCAFC9-6D4E-41EA-87ED-F1736C4050C7Q58695419-3DC85DDC-04B6-4674-A30F-EBE994650502Q58916049-DDE0814F-FE71-43B7-B5BC-15F674C5022C
P2860
Bacterial proteomics and its role in antibacterial drug discovery.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Bacterial proteomics and its role in antibacterial drug discovery.
@ast
Bacterial proteomics and its role in antibacterial drug discovery.
@en
type
label
Bacterial proteomics and its role in antibacterial drug discovery.
@ast
Bacterial proteomics and its role in antibacterial drug discovery.
@en
prefLabel
Bacterial proteomics and its role in antibacterial drug discovery.
@ast
Bacterial proteomics and its role in antibacterial drug discovery.
@en
P2860
P356
P1476
Bacterial proteomics and its role in antibacterial drug discovery.
@en
P2093
Harald Labischinski
Heike Brötz-Oesterhelt
P2860
P304
P356
10.1002/MAS.20030
P577
2005-07-01T00:00:00Z